Orion stock holds steady as investors await fresh earnings
Published on 08/25/2026 at 14:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Orion stock sits in the spotlight as Orion Corporation (FI0009014377) trades on Nasdaq Helsinki with a recent quote of EUR 25.50, down 0.58%, and a market value of about EUR 3.19 billion as of August 25, 2026. The latest market snapshot also shows a trading range of EUR 25.50 for the session and volume of 0.00K shares, putting the move into a very tight frame.
Market setup
The pricing backdrop is giving investors a narrow corridor to judge the name. In the same market snapshot, the stock is shown at EUR 25.50 after a 0.58% decline, while the market cap stands at EUR 3.19 billion and the share count traded is flat in the captured view.
That makes the next reported figures the real reference point for Orion's valuation. The company recently reported first-half 2026 results, and the market is still weighing how that operating picture translates into the shares now.
Half-year numbers
For H1 2026, Orion posted net sales of EUR 718.4 million and operating profit of EUR 216.3 million, according to the latest earnings summary. Net sales rose 3.8% year over year, which gives the stock a concrete growth comparison even before the next update arrives.
Another useful anchor is profitability: operating profit of EUR 216.3 million on EUR 718.4 million of sales points to a strong margin profile for the period. That mix matters because it shows Orion is not leaning on volume alone.
What matters next
Investors are also watching the reported period itself, not just the publication date. The current reference point remains H1 2026, which is within the freshness window and therefore more relevant than older annual figures for judging the stock today.
Historical context still helps frame the move. In fiscal 2025, Orion's revenue and profit base were already well established, but the fresh H1 2026 figures show the business is still expanding on top of that base rather than standing still.
Product angle
A representative product line is Dexdor, Orion's hospital sedative brand, which helps illustrate the company's specialty-pharma mix. That product family sits alongside other prescription medicines, and the portfolio mix is part of why investors follow the company beyond one quarter.
Shares and venue
Orion shares are quoted in euros on Nasdaq Helsinki, and the latest captured level of EUR 25.50 gives the market a simple line to watch as new company numbers emerge. The combination of a EUR 3.19 billion market value and H1 2026 sales of EUR 718.4 million keeps the stock grounded in hard figures rather than headlines alone.
Fact box
Company: Orion Corporation
ISIN: FI0009014377
Ticker: ORNBV
Exchange: Nasdaq Helsinki
Price: EUR 25.50
Market cap: EUR 3.19 billion
Sector / Industry: Health Care / Pharmaceuticals
Index membership: OMX Helsinki 25
Media description
Orion shares on Nasdaq Helsinki
Media alt
Orion stock on Helsinki market
